|Videos|July 9, 2021
Dr. Gupta on current and future urothelial carcinoma research
Author(s)Urology Times staff
In this video, Shilpa Gupta, MD, discusses the rapidly evolving world of research on urothelial carcinoma.
Advertisement
In this interview, Shilpa Gupta, MD, also gives an overview of the current state of first-line treatment for urothelial carcinoma. Gupta is the Director of the Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5